TABLE 2.
Antibiotic | No. of cases |
Concordance (%) |
|||||||
---|---|---|---|---|---|---|---|---|---|
Phenotypea |
Genotype |
||||||||
NGD |
Research analysis |
NGD vs phenotype | Research analysis vs phenotype | NGD vs research analysis | |||||
R | S | R | S | R | S | ||||
Methicillin | 17 | 0 | 17 | 0 | 17 | 0 | 100 | 100 | 100 |
Erythromycin | 9 | 7 | 9 | 7 | 9 | 7 | 100 | 100 | 100 |
Fusidic acid | 3 | 13 | 2 | 14 | 2 | 14 | 93.75 | 93.75 | 100 |
Gentamicin | 0 | 16 | 0 | 16 | 0 | 16 | 100 | 100 | 100 |
Rifampicin | 0 | 16 | 0 | 16 | 0 | 16 | 100 | 100 | 100 |
Tetracycline | 4 | 12 | 4 | 12 | 4 | 12 | 100 | 100 | 100 |
Chloramphenicol | 0 | 15 | 0 | 15 | 0 | 15 | 100 | 100 | 100 |
Ciprofloxacin | 12 | 3 | 12 | 3 | 12 | 3 | 100 | 100 | 100 |
Linezolid | 0 | 15 | 0 | 15 | 0 | 15 | 100 | 100 | 100 |
Mupirocin | 0 | 15 | 0 | 15 | 0 | 15 | 100 | 100 | 100 |
Total | 45 | 97 | 44 | 98 | 44 | 98 | 0.99 | 0.99 | 100 |
R, resistant; S, susceptible.